Arbi D Tablet 300/25mg

About Arbi D Tablet 300/25mg

Arbi D Tablet 300/25mg Uses

• Treats resistant or difficult-to-control hypertension in adults who require the maximum doses of both irbesartan and hydrochlorothiazide.
• Used when previous combination therapy with lower doses has been insufficient to achieve blood pressure targets.
• Reduces the elevated cardiovascular risk associated with persistent high blood pressure that has not responded to standard antihypertensive regimens.
• May be used in patients with hypertensive heart disease or hypertension complicated by multiple risk factors requiring aggressive blood pressure control.

Arbi D Tablet 300/25mg Benefits

• Delivers the maximum recommended doses of both irbesartan (300mg) and hydrochlorothiazide (25mg) in a single once-daily tablet.
• The 25mg hydrochlorothiazide dose provides greater natriuretic effect and more pronounced blood volume reduction compared to the 12.5mg variant.
• Simplifies a complex antihypertensive regimen into a single tablet, supporting adherence in patients who may already be on multiple medications.
• Suitable for patients who have demonstrated tolerability to both components at lower doses and require further blood pressure reduction.
• Appropriate for adults with high cardiovascular risk where achieving blood pressure targets is a clinical priority.

What Experts Say

Cardiologists reserve Arbi D 300/25mg for patients with resistant or difficult-to-control hypertension who require the maximum doses of both the ARB and diuretic components. The higher hydrochlorothiazide dose of 25mg provides a more pronounced natriuretic effect than the 12.5mg variant, reducing blood volume to a greater degree and contributing additional blood pressure reduction in patients with persistent hypertension.

At the 25mg hydrochlorothiazide dose, physicians monitor patients closely for electrolyte disturbances, particularly hypokalemia (low potassium) and hyponatremia (low sodium), which are the most clinically significant dose-related risks of thiazide diuretics. Some patients on this combination may benefit from dietary potassium guidance or supplementation as directed by their physician.

Cardiologists reserve the maximum-dose combination in Arbi D 300/25mg for patients confirmed to be inadequately controlled on lower doses. The higher diuretic component increases the risk of volume depletion and electrolyte imbalance, making regular monitoring of blood pressure, kidney function, and electrolytes essential throughout treatment.

Drug Class

• Angiotensin II receptor blocker (ARB) and thiazide diuretic combination

Arbi D Tablet 300/25mg formula

• Irbesartan + Hydrochlorothiazide

Available forms

• Tablet

How to use Arbi D Tablet 300/25mg?

• Take one Arbi D 300/25mg tablet once daily at the same time each day, preferably in the morning to minimize nighttime diuresis.
• Take with or without food. Swallow the tablet whole with water — do not crush or split.
• Maintain adequate fluid intake throughout treatment, particularly during hot weather, physical exertion, or illness, to compensate for the stronger diuretic effect at this dose.
• Attend regular follow-up appointments for blood pressure readings, kidney function tests, and electrolyte monitoring, as required at this maximum dose.
• Do not stop taking Arbi D 300/25mg without medical advice. Abrupt discontinuation can cause a rapid rebound in blood pressure.

Drug Interactions

Arbi D 300/25mg has the broadest interaction profile of the Arbi D range due to the maximum doses of both components. Review all concurrent medications with your physician before initiation.

• NSAIDs and COX-2 inhibitors: Particularly hazardous in combination with maximum-dose ARB and diuretic due to triple risk of acute kidney injury. Avoid concurrent regular use.
• Potassium-lowering drugs (corticosteroids, laxatives, beta-2 agonists): Combined with hydrochlorothiazide 25mg, these agents can cause severe hypokalemia. Potassium levels must be monitored closely.
• Digoxin: Hypokalemia from hydrochlorothiazide increases the toxicity risk of digoxin significantly. Maintain potassium in the normal range and monitor digoxin levels.
• Cholestyramine and colestipol: May reduce gastrointestinal absorption of hydrochlorothiazide. Take Arbi D at least one hour before or four to six hours after these medications.

Risks and warnings

• Pregnancy: Absolutely contraindicated in pregnancy. Both irbesartan and high-dose hydrochlorothiazide can cause serious fetal harm, including kidney failure and neonatal death. Stop immediately if pregnancy is confirmed.
• Electrolyte monitoring: The 25mg hydrochlorothiazide dose significantly increases the risk of hypokalemia and hyponatremia. Electrolytes must be checked before initiating treatment and monitored regularly thereafter.
• Dehydration and hypotension: Increased diuresis at this dose can cause significant volume depletion, particularly in older adults or patients in hot environments. Maintain adequate hydration.
• Renal function: Both components can stress renal function at maximum doses. Monitor creatinine and urine output closely, especially in the first weeks of treatment.
• Gout: Hydrochlorothiazide 25mg significantly raises uric acid levels. Patients with gout or hyperuricemia require close monitoring and possible dose adjustment of urate-lowering therapy.

Arbi D Tablet 300/25mg Side Effects

Arbi D 300/25mg carries the highest side-effect burden of the three Arbi D strengths, reflecting the maximum doses of both active components. Monitoring is essential during treatment.

• Dizziness or postural hypotension, particularly in the elderly or in patients with low baseline blood pressure
• Significant increase in urination, especially in the first weeks of treatment
• Muscle cramps, weakness, or palpitations from electrolyte changes
• Fatigue or headache during dose adjustment

The following effects are clinically important and require prompt medical review.

• Severe hypokalemia causing irregular heartbeat, weakness, or muscle paralysis
• Significant rise in creatinine or reduced urine output indicating renal impairment
• Angioedema (facial or throat swelling) — stop treatment immediately and seek emergency care

Storage Conditions

• Store at a stable room temperature not exceeding 25°C in a tightly closed container. Temperature fluctuations are particularly problematic for the higher hydrochlorothiazide component in this formulation.
• Avoid storing near windows, stoves, or in warm areas of the home where temperature cannot be reliably controlled.
• Keep in the original sealed packaging. Do not transfer tablets to an unsealed organizer for daily use at this dose strength, as moisture exposure can alter tablet integrity.
• Keep out of reach of children. This is a high-dose prescription antihypertensive and must be stored securely.
• Check the expiry date before each use. Discard the pack if any tablets appear discolored, swollen, or show signs of moisture exposure.